| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |